Medtronic Hopes To Disrupt Event-Recorder Space With Corventis Buy
This article was originally published in The Gray Sheet
Executive Summary
Medtronic will exercise its option to acquire Corventis to bring its non-invasive cardiac telemetry technologies to the U.S. and Europe by later this year.
You may also be interested in...
iRhythm Secures $17 Million For Holter Monitor Replacement
The startup will use the Series E funds to support market expansion and evidence collection for its wearable Zio Patch technology and service for detecting heart arrhythmias.
Medtronic Goes Small With Leadless Pacer, Cardiac Monitor
The firm announced the first U.S. implant for its investigational Micra transcatheter, leadless pacing system, and the global launch of its miniature Reveal LINQ implantable cardiac monitor.
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.